389 related articles for article (PubMed ID: 11702086)
1. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
Bruijnzeel AW; Stam R; Wiegant VM
Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
[TBL] [Abstract][Full Text] [Related]
2. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
[TBL] [Abstract][Full Text] [Related]
3. Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.
Merali Z; Khan S; Michaud DS; Shippy SA; Anisman H
Eur J Neurosci; 2004 Jul; 20(1):229-39. PubMed ID: 15245495
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
5. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
Yang XM; Gorman AL; Dunn AJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1064-70. PubMed ID: 2262892
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
Martins AP; Marras RA; Guimarães FS
Depress Anxiety; 2000; 12(2):99-101. PubMed ID: 11091933
[TBL] [Abstract][Full Text] [Related]
7. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.
Gutiérrez-Mariscal M; de Gortari P; López-Rubalcava C; Martínez A; Joseph-Bravo P
Psychoneuroendocrinology; 2008 Feb; 33(2):198-213. PubMed ID: 18079066
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
14. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A.
Kaneta T; Kusnecov AW
Brain Behav Immun; 2005 Mar; 19(2):138-46. PubMed ID: 15664786
[TBL] [Abstract][Full Text] [Related]
15. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
Zieba B; Grzegorzewska M; Brański P; Domin H; Wierońska JM; Hess G; Smiałowska M
Neuropeptides; 2008; 42(5-6):513-23. PubMed ID: 18617263
[TBL] [Abstract][Full Text] [Related]
16. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
17. Involvement of central, but not placental corticotropin releasing hormone (CRH) in heat stress induced immunosuppression during pregnancy.
Nakamura H; Nagase H; Ogino K; Hatta K; Matsuzaki I
Brain Behav Immun; 2001 Mar; 15(1):43-53. PubMed ID: 11259079
[TBL] [Abstract][Full Text] [Related]
18. Differential behavioral and endocrinological effects of corticotropin-releasing hormone (CRH) in the Syracuse high- and low-avoidance rats.
Gupta P; Brush FR
Horm Behav; 1998 Dec; 34(3):262-7. PubMed ID: 9878275
[TBL] [Abstract][Full Text] [Related]
19. Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic-pituitary-adrenal axis and induces anxiety-like behavior in adult male rat offspring.
Fan JM; Chen XQ; Jin H; Du JZ
Neuroscience; 2009 Apr; 159(4):1363-73. PubMed ID: 19409200
[TBL] [Abstract][Full Text] [Related]
20. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
